| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.04T | 14.66T | 13.32T | 14.31T | 11.76T | 8.01T |
| Gross Profit | 1.31T | 1.29T | 1.32T | 1.40T | 1.14T | 811.47B |
| EBITDA | 1.08T | 1.65T | 1.28T | 912.70B | 801.22B | 411.13B |
| Net Income | 860.12B | 900.34B | 1.06T | 1.13T | 914.72B | 335.46B |
Balance Sheet | ||||||
| Total Assets | 19.90T | 16.81T | 16.90T | 15.38T | 14.92T | 12.52T |
| Cash, Cash Equivalents and Short-Term Investments | 858.00B | 979.75B | 902.72B | 1.40T | 1.17T | 1.10T |
| Total Debt | 5.81T | 5.28T | 5.17T | 5.40T | 5.19T | 5.04T |
| Total Liabilities | 11.23T | 9.05T | 9.13T | 8.82T | 9.13T | 7.69T |
| Stockholders Equity | 8.43T | 7.55T | 7.54T | 6.37T | 5.61T | 4.57T |
Cash Flow | ||||||
| Free Cash Flow | -371.35B | 671.37B | 569.65B | 819.47B | 621.37B | 557.01B |
| Operating Cash Flow | 724.09B | 1.02T | 864.42B | 1.05T | 806.90B | 772.70B |
| Investing Cash Flow | -1.11T | -161.99B | -427.55B | -178.34B | -181.19B | -322.47B |
| Financing Cash Flow | 274.60B | -749.60B | -1.01T | -634.68B | -614.33B | -486.96B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥9.40T | 14.11 | 13.39% | 2.29% | 9.62% | 25.71% | |
71 Outperform | ¥16.17T | 16.87 | 15.23% | 2.11% | 0.93% | 15.80% | |
70 Outperform | ¥6.60T | 13.91 | 13.49% | 2.10% | 5.32% | 9.73% | |
69 Neutral | ¥7.06T | 15.10 | 12.86% | 2.48% | 3.19% | 72.26% | |
68 Neutral | ¥21.06T | 13.18 | 7.39% | 2.94% | -7.54% | -35.70% | |
67 Neutral | ¥17.84T | 17.68 | 11.47% | 2.28% | -1.33% | -7.40% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |